Literature DB >> 2572556

Role of L3T4+ lymphocytes in protective immunity to systemic Candida albicans infection in mice.

E Cenci1, L Romani, A Vecchiarelli, P Puccetti, F Bistoni.   

Abstract

Protective immunity to lethal Candida albicans challenge in vivo and activation of splenic macrophages with highly candidacidal activity in vitro were detected in mice infected with low-virulence agerminative yeast cells of the variant strain PCA-2, at a time when a strong delayed-type hypersensitivity (DTH) reaction to C. albicans occurred in the footpads of PCA-2-treated mice. The DTH reaction was transferable with spleen cell populations from these animals, and enrichment of splenic lymphocytes in L3T4+ cells significantly increased the footpad swelling. The reactivity transferred by L3T4+ cells was a radiosensitive (2,500 rads in vitro) phenomenon that required collaboration with radioresistant, silica-sensitive syngeneic cells in the host and was inhibited by treatment of recipient mice with antibodies to the L3T4 antigen or murine gamma interferon. In vitro, the PCA-2-immune L3T4+ cells produced various lymphokine activities upon incubation with C. albicans, including gamma interferon and granulocyte-macrophage colony-stimulating factor. Anti-L3T4 monoclonal antibody treatment of PCA-2-infected mice significantly impaired their footpad reaction and resistance to C. albicans, as shown by increased recovery of yeast cells from the kidneys of anti-L3T4-treated mice. These results suggested that the mechanisms of anti-Candida resistance induced by PCA-2 may involve specific induction of a DTH response mediated by inflammatory L3T4+ T cells and lymphokine-activated phagocytic effectors. However, the survival rate of the PCA-2-immune mice challenged with C. albicans was not significantly modified by administration of the anti-L3T4 antibody, thus allowing for the conclusion that compensatory mechanisms lead to considerable anti-Candida resistance when the activity of L3T4+ cells is deficient.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2572556      PMCID: PMC259871          DOI: 10.1128/iai.57.11.3581-3587.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

1.  Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection.

Authors:  M Belosevic; C E Davis; M S Meltzer; C A Nacy
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

Review 2.  T lymphocyte-macrophage interactions in cellular antibacterial immunity.

Authors:  H Hahn; S H Kaufmann
Journal:  Immunobiology       Date:  1982-04       Impact factor: 3.144

3.  A radiolabel release microassay for phagocytic killing of Candida albicans.

Authors:  F Bistoni; M Baccarini; E Blasi; P Puccetti; P Marconi
Journal:  J Immunol Methods       Date:  1982-08-13       Impact factor: 2.303

4.  Role of activated macrophages in resistance to systemic candidosis.

Authors:  A Baghian; K W Lee
Journal:  J Leukoc Biol       Date:  1988-09       Impact factor: 4.962

5.  Preparative nonlytic separation of Lyt2+ and Lyt2- T lymphocytes, functional analyses of the separated cells and demonstration of synergy in graft-vs.-host reaction of Lyt2+ and Lyt2- cells.

Authors:  M Mage; B Mathieson; S Sharrow; L McHugh; U Hämmerling; C Kanellopoulos-Langevin; D Brideau; C A Thomas
Journal:  Eur J Immunol       Date:  1981-03       Impact factor: 5.532

6.  Efficacy of granulocyte transfusions in the control of systemic candidiasis in the leukopenic host.

Authors:  R C Ruthe; B R Andersen; B L Cunningham; R B Epstein
Journal:  Blood       Date:  1978-09       Impact factor: 22.113

7.  Absence of correlation between delayed-type hypersensitivity and protection in experimental systemic candidiasis in immunized mice.

Authors:  B Hurtrel; P H Langrange; J C Michel
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

8.  Effects of cyclophosphamide on murine candidiasis.

Authors:  S A Moser; J E Domer
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

9.  An in vitro model for Toxoplasma infection in man. Interaction between CD4+ monoclonal T cells and macrophages results in killing of trophozoites.

Authors:  A Canessa; V Pistoia; S Roncella; A Merli; G Melioli; A Terragna; M Ferrarini
Journal:  J Immunol       Date:  1988-05-15       Impact factor: 5.422

10.  Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition.

Authors:  J W Kappler; B Skidmore; J White; P Marrack
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

View more
  35 in total

1.  Gamma interferon modifies CD4+ subset expression in murine candidiasis.

Authors:  L Romani; E Cenci; A Mencacci; R Spaccapelo; U Grohmann; P Puccetti; F Bistoni
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

2.  Susceptibility of beige mutant mice to candidiasis may be linked to a defect in granulocyte production by bone marrow stem cells.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

3.  Effect of Friend leukemia virus infection on susceptibility to Candida albicans.

Authors:  M A Moors; S M Jones; K K Klyczek; T J Rogers; H R Buckley; K J Blank
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

4.  CD4(+)-T-Cell-mediated resistance to systemic murine candidiasis induced by a membrane fraction of Candida albicans.

Authors:  S Mizutani; M Endo; T Ino-Ue; M Kurasawa; Y Uno; H Saito; K Onogi; I Kato; K Takesako
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

5.  Immunomodulatory effects of anti-CD4 antibody in host resistance against infections and tumors in human CD4 transgenic mice.

Authors:  D J Herzyk; E R Gore; R Polsky; K L Nadwodny; C C Maier; S Liu; T K Hart; A G Harmsen; P J Bugelski
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

6.  NK cells mediate increase of phagocytic activity but not of proinflammatory cytokine (interleukin-6 [IL-6], tumor necrosis factor alpha, and IL-12) production elicited in splenic macrophages by tilorone treatment of mice during acute systemic candidiasis.

Authors:  José Juan Gaforio; Elena Ortega; Ignacio Algarra; María José Serrano; Gerardo Alvarez de Cienfuegos
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

7.  CD86 (B7-2), but not CD80 (B7-1), expression in the epidermis of transgenic mice enhances the immunogenicity of primary cutaneous Candida albicans infections.

Authors:  A A Gaspari; R Burns; A Nasir; D Ramirez; R K Barth; C G Haidaris
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice.

Authors:  A Mencacci; A Torosantucci; R Spaccapelo; L Romani; F Bistoni; A Cassone
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  The secretion of aspartyl proteinase, a virulence enzyme, by isolates of Candida albicans from the oral cavity of HIV-infected subjects.

Authors:  F De Bernardis; M Boccanera; L Rainaldi; C E Guerra; I Quinti; A Cassone
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

10.  Antigen-specific cytolysis of infected cells in murine candidiasis.

Authors:  L Romani; S Mocci; E Cenci; A Mencacci; G Sbaraglia; P Puccetti; F Bistoni
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.